SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 20-F - Notification of inability to timely file Form 20-F:
SEC Accession No. 0001213900-21-023413
Filing Date
2021-04-29
Accepted
2021-04-29 10:05:18
Documents
1
Period of Report
2020-12-31
Effectiveness Date
2021-04-29

Document Format Files

Seq Description Document Type Size
1 NOTIFICATION OF LATE FILING ea140093-nt20f_biondvax.htm NT 20-F 28602
  Complete submission text file 0001213900-21-023413.txt   29734
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: NT 20-F | Act: 34 | File No.: 001-37353 | Film No.: 21867653
SIC: 2836 Biological Products, (No Diagnostic Substances)